The cell and developmental biologist Prof. Alex Schier, from the Biozentrum of the University of Basel, has been recognized for his work on embryonic development, in particular, for establishing and applying genetic and…
It was only at the beginning of the year that the Biozentrum spin-off Aukera Therapeutics qualified for the BaseLaunch Accelerator program. Now the two young entrepreneurs Dr. Stefan Imseng and Dr. Dritan Liko can add…
A Swiss globetrotter May 2013 He is a scientist, founder of a company, businessman and currently CEO of the biotechnology company Cytos. He lives in Switzerland, the USA and Germany. The Biozentrum alumnus Christian Itin…
Preventing “drill & fill” June 2019 He has been searching for years for the magic formula to spare us from having to visit the dentist. But André Brunella, Head of Product Development for the oral care brands elmex and…
A heart and soul patent attorney November 2014 Even before she began her studies, Isabelle Schubert knew where her career path would lead her. When asked about her profession, her eyes beam with delight. Her work as a patent…
Alumni Portrait Ina Sonnen, Research Group Leader at the Hubrecht Institute in Utrecht June 2025 Childhood dream: Becoming a scientist Since she was a child, Ina Sonnen dreamed of becoming a cancer researcher. Although her…
Define your story, forget the fears. May 2016 Nobody can stop her. Effervescent, waving her hands and laughing, Natalya Izergina recounts the story of her relocation from Russia to Switzerland, when she couldn’t speak either…
Trinational Studies in Biotechnology Strasbourg – Freiburg – Basel, three cities, three universities. Together they offer the unique opportunity of studying across the borders. The interdisciplinary diploma course in…
Testimonial Victoire Tribout EPFL Lausanne, Research Group Sebastian Hiller Where do you come from and what are you studying? I grew up in Paris and now I study in Lausanne in the French part of Switzerland. I have just…
The WHO calls the creeping and rapidly growing number of antibiotic-resistant bacteria a “silent pandemic”. The crisis is aggravated by the fact that hardly any new drugs have come onto the market in recent decades. Even…
This website uses cookies to collect data from users and improve functionality. By continuing to browse the site you are agreeing to this. Receive more information by reading our privacy policy.